Montis Biosciences
Develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.
Launch date
Employees
Market cap
-
Enterprise valuation
€33—49m (Dealroom.co estimates Feb 2020.)
Company register number 0730.979.429
Leuven Flemish Brabant (HQ)
Authorizing premium user...